Early Diagnosis Campaign: Sometimes it's PH

Campaign Committees

Lynette M. Brown, MD, PhD

Lynette M. Brown, MD, PhD, Early Diagnosis Campaign, Chair
Dr. Lynn Brown is an assistant professor at the University of Utah School of Medicine, Division of Pulmonary Critical Care. She is also associate director of the pulmonary hypertension program at Intermountain Medical Center, Murray, Utah. Dr. Brown is board certified in internal medicine and pulmonary diseases. She earned her medical degree at Johns Hopkins School of Medicine, where she also completed a fellowship in pulmonary critical care medicine. Dr. Brown has published articles in peer-reviewed journals on the subject of time to diagnosis of pulmonary hypertension. She is also a member of the American College of Chest Physicians and the American Thoracic Society.


C. Greg Elliott, MD, MACP, FCCP

C. Greg Elliott, MD, MACP, FCCP, Early Diagnosis Campaign, Mentor
Dr. Greg Elliott is a professor at the University of Utah School of Medicine, Division of Pulmonary Critical Care and Chief of the pulmonary hypertension program at Intermountain Medical Center, Murray, Utah. After earning his medical degree from the University of Maryland, he completed a fellowship at Utah where he studied vascular changes associated with acute respiratory distress syndrome by administering vasodilators to patients. A broad spectrum of service characterizes Dr. Elliott’s career, including a long history of service to the NIH, the American Thoracic Society, the American College of Physicians, the American Heart Association, and PHA. At PHA, Dr. Elliott served as the second chair of what is now the Scientific Leadership Council, where he continues to serve the association, and chaired the Scientific Sessions at the 2006 Conference. In addition to his award as Outstanding Physician at the 2006 conference, he has won numerous teaching awards for his work with medical and graduate students, residents and fellows. In the publishing arena, he has over 90 peer-reviewed publications and numerous book chapters and presentations.

Education Committee

The Education Committee is charged with developing new educational resources designed to impact diagnosis and treatment of PH. In addition, the committee seeks to leverage PHA’s existing medical education programs for the purpose of reaching key audiences beyond traditional purveyors of PH care and equipping non-PH specializing clinicians to evaluate cases of suspected PH with confidence.

Committee Members:

  • Tim Lahm, MD, Indiana University, Chair
  • Vinicio de Jesus Perez, MD, Stanford
  • Bonnie Hudak, MD, Nemours Children’s Clinic – Florida
  • John Kingrey, MD, Oklahoma Heart Institute
  • Deborah Levine, MD, University of Texas Health Science Center – San Antonio
  • David Poch, MD, UCSD

Medical Communications Committee

The Medical Communications Committee is charged with identifying and creating new opportunities to communicate information relating to early diagnosis of PH. The Committee develops materials and resources designed to address common hurdles impacting PH diagnosis and to facilitate earlier and more accurate recognition of the disease. The Medical Communications Committee also actively develops opportunities for speaking, teaching, and publishing on issues related to diagnosis and treatment of PH.

Committee Members:

  • (Hyong) Nick Kim, MD, UCSD, Chair
  • Todd Bull, MD, University of Colorado
  • Veronica Franco, MD, Ohio State
  • Peter Leary, MD, University of Washington
  • Jeff Michaelson, MD, Wellstar Medical Group, Pulmonary – Atlanta

Subcommittee on Early Diagnosis of CTEPH Patients

The Subcommittee on the Early Diagnosis of CTEPH Patients provides recommendations and strategies facilitating reduced diagnostic delays of CTEPH, as well as what metrics might be utilized to measure the impact of these recommendations. The committee will also provide the necessary medical expertise and support to optimally benefit CTEPH patients, both within and without the PHA community, and will seek to impact findings that appropriate screening modalities for CTEPH are under-utilized, even with an expert care environment.

Committee Members:

  • William (Bill) Auger, MD, UCSD, Chair
  • David Badesch, MD, University of Colorado
  • Rich Channick, MD, Massachusetts General
  • Paul Forfia, MD, Temple University
  • Gustavo, Heresi-Davila, MD, Cleveland Clinic
  • Manreet Kanwar, MD, FACC, Temple University
  • David Poch, MD, UCSD
  • Ivan Robbins, MD Vanderbilt
  • Victor Test, MD, Texas Tech University
  • Terence Trow, MD, Yale School of Medicine